Cephalon’s Oncologic Treanda On Track For Q4 NDA Filing
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm's initial goal is non-Hodgkin's lymphoma, but plans are in place for studies in chronic lymphocytic leukemia, mantle cell lymphoma and small-cell lung.